Drug discovery services are outsourced scientific expertise and resources (from CROs/CDMOs like Charles River, Eurofins, Labcorp, Selvita) that help pharma/biotech companies find, design, and optimize drug candidates, covering everything from early target ID, hit finding, lead optimization (chemistry/biology/DMPK/ADME/PK/Tox) to preclinical testing, using integrated or standalone models to accelerate bringing potential new medicines to clinic faster and more efficiently, notes Charles River Laboratories, Eurofins Discovery, Labcorp, and Selvita. These services manage complex processes like screening, chemistry, biology, pharmacology, and safety, allowing clients to focus on core R&D or navigate specific technical hurdles.
Key Service Areas
Target Validation & Hit Finding: Identifying promising biological targets and initial compounds (hits) through screening.
Chemistry: Medicinal chemistry, synthetic chemistry, computational chemistry (CADD), and structure-activity relationship (SAR) studies to create better molecules.
Biology: In vitro/vivo assays, target profiling (kinases, GPCRs), pathway analysis, cell-based assays, and mechanism of action studies.
Pharmacology & DMPK/ADME: Studying drug absorption, distribution, metabolism, excretion, and pharmacokinetics (how the body affects the drug).
Preclinical & Safety: Toxicology, safety assessments, and formulation development for animal/human studies.
Biologics/Biotherapeutics: Services for antibodies, peptides, and protein-based drugs.
How They Work
Integrated Programs: Full-service partnerships from early discovery to preclinical candidate selection.
Standalone Projects: Specific studies for a single phase (e.g., just screening or just DMPK).
Technology & Modalities: Utilizing AI, proprietary compound libraries, and supporting various drug types (small molecules, antibodies, degraders).
Why Companies Use Them
Access Expertise & Resources: Gain specialized skills and state-of-the-art facilities without large capital investment.
Accelerate Timelines: Speed up the lengthy drug discovery process.
Reduce Risk: Improve candidate quality and predict safety earlier.
Focus on Core Strengths: Allow internal teams to concentrate on other areas.
www.eXinvest.ae
This email address is being protected from spambots. You need JavaScript enabled to view it.
